drugset / Trial / NCT00943852

The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)

NCT00943852

Phase 1 Completed 13 enrolled Organon and Co
RandomizedCrossoverDouble-blindDiagnostic

Summary

This study will qualify a functional model that can measure central blood pressure and vascular compliance effects through noninvasive means.

Timeline

Start
2006-08
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isosorbide Mononitrate Other / unclassified 15 mg
Comparator Isosorbide Mononitrate Other / unclassified 60 mg
Comparator Losartan Other / unclassified 100 mg

Indications